Cleveland Clinic’s Department of Biomedical Engineering is committed to investigation, innovation and translation of scientific discoveries to enhance patient care. Medical innovation is at the heart of our mission – indeed, our "calling" – and we have a proven track record of patenting and product commercialization.

Volcano and the Cleveland Clinic engaged in a development relationship for the Clinic’s coronary plaque characterization technology, which has resulted in its commercial availability in Volcano’s industry-leading intravascular ultrasound (IVUS) product line. VH® IVUS technology uses advanced, proprietary spectral analysis techniques to classify plaque into 4 tissue types with 93-97% accuracy. Based on 10 years of research with over 200 scientific publications in peer-reviewed journals, the technology allows for simplified image interpretation and a complete view into the severity of a patient's disease. For more information visit:

Cleveland Heart, Inc. has partnered with the Cleveland Clinic to develop the next generation of mechanical cardiac circulatory assist devices with the potential to provide a complete range of treatment options for patients suffering from irreversible end-stage heart failure. Cleveland Heart’s novel cardiac assist technology was invented and championed by a team in Cleveland Clinic’s department of Biomedical Engineering led by Leonard Golding MD. Products in development include a left ventricular assist device for treatment of heart failure and a total artificial heart replacement. For more information visit:

D. Geoffrey Vince, PhD
Department Chair
Phone: (216) 445-6980
Fax: (216) 445-6083
web site